Virtus ETF Advisers’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
P
Virtus ETF Advisers's BNTX Position: Q1 2025 in Review
Virtus ETF Advisers sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 2,897 shares — an estimated $330K sold.
Virtus ETF Advisers first reported a position in BNTX in Q2 2020 and held it in 19 quarters. The position peaked at $631K in Q1 2021. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.
- Virtus ETF Advisers reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
- Virtus ETF Advisers sold 2,897 BioNTech shares in Q1 2025, an estimated $330K.
- Virtus ETF Advisers first reported a position in BioNTech in Q2 2020 and held it in 19 quarters.
- Virtus ETF Advisers's BioNTech position peaked at $631K in Q1 2021.
- 280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.
Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.